Statements (36)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:acquiredBy |
gptkb:Clarient
gptkb:Genoptix |
| gptkbp:CEO |
gptkb:Chris_Smith
|
| gptkbp:foundedYear |
2001
|
| gptkbp:headquartersLocation |
gptkb:Fort_Myers,_Florida,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
NeoGenomics
|
| gptkbp:industry |
gptkb:biotechnology
healthcare diagnostics |
| gptkbp:laboratoriesIn |
gptkb:Europe
gptkb:Singapore gptkb:United_States |
| gptkbp:listedOn |
gptkb:Russell_2000_Index
|
| gptkbp:numberOfEmployees |
over 1,700
|
| gptkbp:offersService |
cytogenetics
anatomic pathology flow cytometry clinical testing molecular testing FISH testing genomic profiling pharma services |
| gptkbp:publiclyTraded |
yes
|
| gptkbp:serves |
oncologists
pathologists pharmaceutical companies academic centers |
| gptkbp:specializesIn |
molecular diagnostics
pathology services cancer genetic testing |
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:NEO
|
| gptkbp:website |
https://www.neogenomics.com/
|
| gptkbp:bfsParent |
gptkb:Inivata
|
| gptkbp:bfsLayer |
7
|